-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pregnant women may need treatment for their medical conditions, such as mood disorders or epilepsy
"In previous studies, we have shown that changes in cortical activity during sleep may provide important information about the neurological status of infants," said senior researcher Anton Tokariev
Studies have shown that exposure to antiepileptic and antidepressant drugs during fetal life leads to widespread changes in cerebral cortical networks, and that these effects may be related to the type of drug exposure
"The clinical significance of these findings is that some EEG findings are associated with subsequent neuropsychological development in children
New insights into early brain development
These studies provide a novel approach to assessing the effects of pharmaceutical formulations on the development of brain function in children
Professor Sampsa Vanhatalo said: "The EEG measurement technology developed by the BABA Centre and its associated state-of-the-art mathematical assessment of neural networks in the brain constitutes a breakthrough in early neurodevelopmental clinical research
Of particular importance, Vanhatalo believes, these EEG-based measurements open a window into how neurons work between cells
"Our new approach provides a general analytical framework to support future broad studies of how fetal brain development is affected by changes in the intrauterine environment
